GSK to buy Bostonâs lead drug asset for liver disease for $2 billion in cash
HQ Team May 14, 2025: GSK Plc will acquire Boston Pharmaceuticalâs investigational lead asset, efimosfermin alfa, to treat serious liver diseases, for $2
HQ Team May 14, 2025: GSK Plc will acquire Boston Pharmaceuticalâs investigational lead asset, efimosfermin alfa, to treat serious liver diseases, for $2
HQ Team May 14, 2025: UN relief chief Tom Fletcher has told the Security Council that the ambassadors must finally act decisively “to
HQ Team May 13, 2025: Bonobos, often called pygmy chimpanzees, use the human equivalent of word compounds and phrasings, allowing Harvard researchers to
 HQ Team May 13, 2025: Antibiotic use in girls in the first year of life, especially in the first three months, may be
HQ Team May 13, 2025: AstraZenecaâs POTOMAC Phase III trial has demonstrated that combining Imfinzi (durvalumab) with standard Bacillus Calmette-GuĂ©rin (BCG) therapy significantly improves disease-free survival (DFS) in patients
By Aparna S. May 13, 2025: Soon after board exam results are declared each year in Kerala, streets are adorned with brightly colored
HQ Team May 12, 2025: The Food and Drug Administration has cleared the first at-home cervical cancer screening test in the US, according
HQ Team May 12, 2025: The world’s richest 10% are responsible for nearly two-thirds of the observed global warming since 1990, a study
HQ Team May 12, 2025: At least 78% of the worldâs nurses are concentrated in countries representing 49% of the population, according to